During pregnancy, fragments of the fetus's DNA circulate in the mother's bloodstream. NIPT involves drawing a blood sample from the mother, from which cffDNA is extracted and analyzed. Advanced sequencing technologies, such as next-generation sequencing (NGS), allow for the detection of genetic abnormalities by comparing the fetal DNA sequence to a reference genome.
